Cargando…

A Novel Prognostic Model Incorporating Carcinoembryonic Antigen in 3-Week or Longer Postoperative Period for Stage III Colon Cancer: A Multicenter Retrospective Study

BACKGROUND: The prognostic stratification of colon cancer using only the tumor-node-metastasis (TNM) stage has some limitations. We sought to increase the accuracy of stratifying patients with stage III colon cancer by constructing a prognostic model combining carcinoembryonic antigen (CEA) with TNM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Jin, Liu, Yanlong, Cai, Xin, Wang, Jingwen, Guo, Rui, Ji, Yuan, Li, Chao, Xu, Ye, Li, Xinxiang, Zhang, Chundong, Zhang, Rui, Zhu, Ji, Cai, Sanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736239/ https://www.ncbi.nlm.nih.gov/pubmed/33335852 http://dx.doi.org/10.3389/fonc.2020.566784

Ejemplares similares

Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study
por: Liu, Qi, et al.
Publicado: (2018)

Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study
por: Liu, Qi, et al.
Publicado: (2019)

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study
por: Luo, Dakui, et al.
Publicado: (2019)

Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer
por: Li, Qingguo, et al.
Publicado: (2016)

Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy
por: Li, Qingguo, et al.
Publicado: (2015)

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
por: Li, Qingguo, et al.
Publicado: (2019)

Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum
por: Li, Qingguo, et al.
Publicado: (2017)

Trajectories of perioperative serum carcinoembryonic antigen and colorectal cancer outcome: A retrospective, multicenter longitudinal cohort study
por: Li, Zhenhui, et al.
Publicado: (2021)

An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 *1*1 genotype
por: Guan, Yun, et al.
Publicado: (2019)

Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery
por: Luo, Dakui, et al.
Publicado: (2021)

Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)
por: Wang, Jingwen, et al.
Publicado: (2019)

Clinicopathological Features of Stage I–III Colorectal Cancer Recurrence Over 5 Years After Radical Surgery Without Receiving Neoadjuvant Therapy: Evidence From a Large Sample Study
por: Luo, Dakui, et al.
Publicado: (2021)

Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer
por: Zhang, Sheng, et al.
Publicado: (2020)

The influence of marital status on stage at diagnosis and survival of patients with colorectal cancer
por: Li, Qingguo, et al.
Publicado: (2015)

P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
por: Liu, Qi, et al.
Publicado: (2018)

Real-World Implications of Nonbiological Factors with Staging, Prognosis and Clinical Management in Colon Cancer
por: Liu, Qi, et al.
Publicado: (2018)

Circumferential resection margin as a prognostic factor after rectal cancer surgery: A large population‐based retrospective study
por: Liu, Qi, et al.
Publicado: (2018)

Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
por: Liu, Qi, et al.
Publicado: (2020)

Pretreatment Carcinoembryonic Antigen Level Serves as a Potential Biomarker to Guide Adjuvant Radiotherapy in pT4N+ Colon Cancer Patients
por: Luo, Dakui, et al.
Publicado: (2023)

Accurate method for value assignment of carcinoembryonic antigen reference materials
por: Zhang, Rui, et al.
Publicado: (2023)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial
por: Liu, Fangqi, et al.
Publicado: (2019)

The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer
por: Shi, Debing, et al.
Publicado: (2015)

Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection
por: Li, Qingguo, et al.
Publicado: (2017)

Persistent High Postoperative Carcinoembryonic Antigen in Colorectal Cancer Patients- Is it Important?
por: Filiz, Ali Ilker, et al.
Publicado: (2009)

High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma
por: Li, Xinxiang, et al.
Publicado: (2015)

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019)

A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer
por: Luo, Dakui, et al.
Publicado: (2020)

Demand for longer quarantine period among common and uncommon COVID-19 infections: a scoping review
por: Li, Zhi-Yao, et al.
Publicado: (2021)

Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer
por: Zhang, Sheng, et al.
Publicado: (2019)

Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen
por: Hong, Hao, et al.
Publicado: (2008)

Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients Than T4 Stage and Preoperative CEA
por: Fenqi, Du, et al.
Publicado: (2022)

Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?
por: Peng, Junjie, et al.
Publicado: (2013)

Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
por: Li, Yaqi, et al.
Publicado: (2016)

Lymph node status as a prognostic factor after palliative resection of primary tumor for patients with metastatic colorectal cancer
por: Li, Qingguo, et al.
Publicado: (2017)

Changes in Incidence and Survival by Decade of Patients With Primary Colorectal Lymphoma: A SEER Analysis
por: Li, Qingguo, et al.
Publicado: (2020)

Poorer prognosis in young female patients with non-metastatic colorectal cancer: a hospital-based analysis of 5,047 patients in China
por: Shen, Lijun, et al.
Publicado: (2018)

TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer
por: Wei, Ping, et al.
Publicado: (2013)

Incidence, predictors and prognostic implications of positive circumferential resection margin in colon cancer: A retrospective study in a Chinese high-volume cancer center
por: Luo, Dakui, et al.
Publicado: (2022)

HER2 status is positively associated with vessel invasion of colorectal cancer: a retrospective large cohort study
por: Wang, Mingdian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_07k2ldsqu0ui1kreuvc6sde92q